NCT03981354

Brief Summary

Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2019

Completed
9 days until next milestone

Study Start

First participant enrolled

May 31, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 10, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

3 years

First QC Date

May 22, 2019

Last Update Submit

May 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline level of hemoglobin at 14 days after surgical operation

    One of the main decision-making factors that guide the clinician to discharge the patient is the hemoglobin level. The association between preoperative hemoglobin and hemoglobin at discharge was already observed in past orthopedic cohorts, with a loss of 3.3 g/dl being considered clinically relevant. Patients with a better nutritional status may have a reduced fall in hemoglobin after the surgical operation.

    Before the surgical operation, after 3 days, after 14 days.

Secondary Outcomes (11)

  • Change from baseline level of pre-albumin at 14 days after surgical operation

    Before the surgical operation, after 3 days, after 14 days.

  • Change from baseline level of total lymphocyte count at 14 days after surgical operation

    Before the surgical operation, after 3 days, after 14 days.

  • Change from baseline level of iron at 14 days after surgical operation

    Before the surgical operation, after 3 days, after 14 days.

  • Change from baseline level of vitamin D at 14 days after surgical operation

    Before the surgical operation, after 3 days, after 14 days.

  • Change from baseline of weight 14 days after surgical operation

    Before the surgical operation, after 3 days, after 14 days.

  • +6 more secondary outcomes

Eligibility Criteria

Age60 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary care clinic

You may qualify if:

  • caucasian
  • arthroplasty intervention program with hip prosthesis placement
  • signature and acceptance of informed consent to collaborate in all the procedures necessary for the study

You may not qualify if:

  • heart failure stage III-IV
  • renal failure stage III-IV
  • actual cancer
  • past neurological disorders (including, but not limited to cerebral ischemia, cerebral haemorrhages, brain tumors, endocranial aneurysms)
  • neurodegenerative disorders (including, but not limited to Alzheimer's dementia, fronto-temporal dementia)
  • actual major psychopharmacological therapies
  • pregnancy certified by self-declaration
  • inability to adhere to the rehabilitation protocol or to carry out the controls
  • non-acceptance of informed consent
  • revision interventions
  • previously established and documented sleep disorders
  • shift or part-time worker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, Italy

Location

MeSH Terms

Conditions

MalnutritionAnemia

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Matteo Briguglio

    IRCCS Istituto Ortopedico Galeazzi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2019

First Posted

June 10, 2019

Study Start

May 31, 2019

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

May 11, 2023

Record last verified: 2023-05

Locations